Abstract
The Hippo signaling pathway has been established as a key regulator of organ size control, tumor suppression, and tissue regeneration in multiple organisms. Recently, emerging evidence has indicated that Hippo signaling might play an important role in regulating the immune system in both Drosophila and mammals. In particular, patients bearing a loss-of-function mutation of MST1 are reported to have an autosomal recessive primary immunodeficiency syndrome. MST1/2 kinases, the mammalian orthologs of Drosophila Hippo, may activate the non-canonical Hippo signaling pathway via MOB1A/B and/or NDR1/2 or cross-talk with other essential signaling pathways to regulate both innate and adaptive immunity. In this review, we present and discuss recent findings of cellular mechanisms/functions of Hippo signaling in the innate immunity in Drosophila and in mammals, T cell immunity, as well as the implications of Hippo signaling for tumor immunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811–828 (2015).
Avruch, J. et al. Protein kinases of the Hippo pathway: regulation and substrates. Semin. Cell Dev. Biol. 23, 770–784 (2012).
Chen, L., Qin, F., Deng, X., Avruch, J. & Zhou, D. Hippo pathway in intestinal homeostasis and tumorigenesis. Protein Cell 3, 305–310 (2012).
Zhang, Q. et al. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Nat. Cell Biol. 19, 362–374 (2017).
Zhou, D. et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc. Natl Acad. Sci. USA 108, E1312–1320 (2011).
Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425–438 (2009).
Wu, H. et al. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. Cell Rep. 3, 1663–1677 (2013).
Fan, F. et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci. Transl. Med. 8, 352ra108 (2016).
Zhang, S. et al. Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2. Cancer Cell 31, 669–684 (2017). e667.
Katagiri, K. et al. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 5, 1045–1051 (2004).
Katagiri, K., Maeda, A., Shimonaka, M. & Kinashi, T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4, 741–748 (2003).
Abdollahpour, H. et al. The phenotype of human STK4 deficiency. Blood 119, 3450–3457 (2012).
Nehme, N. T. et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119, 3458–3468 (2012).
Zhou, D. et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells. Proc. Natl Acad. Sci. USA 105, 20321–20326 (2008).
Mou, F. et al. The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. J. Exp. Med. 209, 741–759 (2012).
Halacli, S. O. et al. STK4 (MST1) deficiency in two siblings with autoimmune cytopenias: a novel mutation. Clin. Immunol. 161, 316–323 (2015).
Liu, J. & Cao, X. Cellular and molecular regulation of innate inflammatory responses. Cell. Mol. Immunol. 13, 711–721 (2016).
Liu, B. et al. Toll receptor-mediated Hippo signaling controls innate immunity in Drosophila. Cell 164, 406–419 (2016).
Dubey, S. K. & Tapadia, M. G. Yorkie regulates neurodegeneration through canonical pathway and innate immune response. Mol. Neurobiol. 55, 1193–1207 (2017).
Geng, J. et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat. Immunol. 16, 1142–1152 (2015).
Li, W. et al. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma. J. Clin. Invest. 125, 4239–4254 (2015).
Boro, M., Singh, V. & Balaji, K. N. Mycobacterium tuberculosis-triggered Hippo pathway orchestrates CXCL1/2 expression to modulate host immune responses. Sci. Rep. 6, 37695 (2016).
Wen, M. et al. Stk38 protein kinase preferentially inhibits TLR9-activated inflammatory responses by promoting MEKK2 ubiquitination in macrophages. Nat. Commun. 6, 7167 (2015).
Kim, N., Park, Y. Y., Joo, C. H. & Kim, H. S. Relief of YAP-mediated inhibition by IKKvarepsilon promotes innate antiviral immunity. Cell. Mol. Immunol. 14, 1–3 (2017).
Wang, S. et al. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKvarepsilon-mediated phosphorylation. Nat. Immunol. 18, 733–743 (2017).
Meng, F. et al. Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation. Genes Dev. 30, 1086–1100 (2016).
Geng, J. et al. The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells. Nat. Immunol. 18, 800–812 (2017).
Katagiri, K. et al. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J. 28, 1319–1331 (2009).
Dong, Y. et al. A cell-intrinsic role for Mst1 in regulating thymocyte egress. J. Immunol. 183, 3865–3872 (2009).
Du, X. et al. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J. Immunol. 192, 1525–1535 (2014).
Katagiri, K., Imamura, M. & Kinashi, T. Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion. Nat. Immunol. 7, 919–928 (2006).
Bai, X. et al. Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels. Blood Adv. 1, 219–230 (2016).
Ueda, Y. et al. Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus. Nat. Commun. 3, 1098 (2012).
Choi, J. et al. Mst1-FoxO signaling protects naive T lymphocytes from cellular oxidative stress in mice. PLoS ONE 4, e8011 (2009).
Tang, F. et al. The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility. Sci. Signal. 8, ra100 (2015).
Cornils, H., Kohler, R. S., Hergovich, A. & Hemmings, B. A. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression. Cell Cycle 10, 1897–1904 (2011).
Cornils, H. et al. Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma. Sci. Signal. 3, ra47 (2010).
Katagiri, K. et al. Deficiency of Rap1-binding protein RAPL causes lymphoproliferative disorders through mislocalization of p27kip1. Immunity 34, 24–38 (2011).
Nishikimi, A. et al. Rab13 acts downstream of the kinase Mst1 to deliver the integrin LFA-1 to the cell surface for lymphocyte trafficking. Sci. Signal. 7, ra72 (2014).
Kondo, N. et al. NDR1-dependent regulation of kindlin-3 controls high-affinity LFA-1 binding and immune synapse organization. Mol. Cell. Biol. 37, e00424–16 2017.
Li, C. et al. Dendritic cell MST1 inhibits Th17 differentiation. Nat. Commun. 8, 14275 (2017).
Li, J. et al. Mammalian sterile 20-like kinase 1 (Mst1) enhances the stability of Forkhead Box P3 (Foxp3) and the function of regulatory T Cells by modulating Foxp3 acetylation. J. Biol. Chem. 290, 30762–30770 (2015).
Tomiyama, T. et al. Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mst1 kinase. PLoS ONE 8, e73874 (2013).
Wang, G. et al. Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov. 6, 80–95 (2016).
Murakami, S. et al. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene 36, 1232–1244 (2017).
Guo, X. et al. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev. 31, 247–259 (2017).
Moroishi, T. et al The hippo pathway kinases LATS1/2 suppress cancer immunity. Cell 167, 1525–1539.e17 (2016).
Thaventhiran, J. E. et al. Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell. Proc. Natl Acad. Sci. USA 109, E2223–2229 (2012).
Acknowledgements
This work was supported by grants from National Key R&D Program of China (2017YFA0504502 to D.Z. and L.C., 2015CB910502 to L.C.), The National Natural Science Foundation of China (U1405225 to L.C.; 31625010, 81790254, and U1505224 to D.Z.; 81472229 to L.H.; 81302529 to X.L.), and the Fundamental Research Funds for the Central Universities of China-Xiamen University (20720180047 to L.C., 20720160071 to D.Z., and 20720160054 to L.H.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Hong, L., Li, X., Zhou, D. et al. Role of Hippo signaling in regulating immunity. Cell Mol Immunol 15, 1003–1009 (2018). https://doi.org/10.1038/s41423-018-0007-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-018-0007-1
Keywords
This article is cited by
-
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Journal of Translational Medicine (2024)
-
MST1/2 exerts a pivotal role in inducing neuroinflammation and Coxsackievirus-A10 replication by interacting with innate immunity
Virology Journal (2024)
-
Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis
Nature Communications (2024)
-
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
Cell Death & Disease (2023)
-
Novel feature selection method via kernel tensor decomposition for improved multi-omics data analysis
BMC Medical Genomics (2022)